Pipeline Therapeutics, Inc.
Records under this name other than patents Pipeline Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 7 of 7 · Back to Pipeline Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,301,266 | Dibenzo azepine compounds and their use in the treatment of otic diseases and disorders Formerly held In force · USPTO record | In force | USPTO record | |
| US 11,512,090 | Muscarinic acetylcholine M1 receptor antagonists Formerly held In force · USPTO record | In force | USPTO record | |
| US 12,390,462 | Muscarinic acetylcholine M1 receptor antagonists Formerly held In force · USPTO record | In force | USPTO record | |
| US 12,054,487 | Muscarinic Acetylcholine M1 Receptor Antagonists Formerly held In force · High confidence | In force | High confidence | |
| US 11,752,149 | Muscarinic acetylcholine M1 receptor antagonists Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,925,872 | Methods of treating cochlear synaptopathy Formerly held Lapsed on the fee record Ended Feb 23, 2025 · USPTO record | Lapsed on the fee record | Ended Feb 23, 2025 | USPTO record |
| US 10,865,188 | Dibenzo azepine compounds and their use in the treatment of otic diseases and disorders Formerly held Lapsed on the fee record Ended Dec 15, 2024 · USPTO record | Lapsed on the fee record | Ended Dec 15, 2024 | USPTO record |